12:00 AM
 | 
Nov 04, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

IV nicardipine-containing medicines regulatory update

EMA's CHMP determined that IV nicardipine-containing medicines should only be used to treat acute life-threatening hypertension and post-operative hypertension. The committee also recommended that nicardipine be given only by continuous infusion...

Read the full 133 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >